Bluebird bio Inc [NASDAQ: BLUE] stock went on a downward path that fall over -1.36% on Monday, amounting to a one-week price increase of more than 7.65%. Over the last 12 months, BLUE stock dropped by -90.67%. The one-year Bluebird bio Inc stock forecast points
Bluebird bio Inc [NASDAQ: BLUE] closed the trading session at $0.36. The stocks have a year to date performance of -74.02 percent and weekly performance of -0.88 percent. The stock has been moved at -62.98 percent over the last six months. The stock has performed
Bluebird bio Inc [NASDAQ: BLUE] traded at a high on Monday, posting a 3.31 gain after which it closed the day’ session at $0.36. The results of the trading session contributed to over 11349267 shares changing hands. Over the past one week, the price volatility
Bluebird bio Inc [NASDAQ: BLUE] loss -8.38% or -0.02 points to close at $0.31 with a heavy trading volume of 4776870 shares. The daily chart for BLUE points out that the company has recorded -69.39% loss over the past six months. If we look at
Bluebird bio Inc [NASDAQ: BLUE] traded at a low on Tuesday, posting a -3.63 loss after which it closed the day’ session at $0.39. The results of the trading session contributed to over 8352732 shares changing hands. Over the past one week, the price volatility
Bluebird bio Inc [NASDAQ: BLUE] closed the trading session at $0.45. The stocks have a year to date performance of -67.22 percent and weekly performance of -8.01 percent. The stock has been moved at -55.21 percent over the last six months. The stock has performed
Bluebird bio Inc [NASDAQ: BLUE] price plunged by -0.61 percent to reach at $0.0. The one-year BLUE stock forecast points to a potential upside of 83.67. The average equity rating for BLUE stock is currently 2.80, trading closer to a bullish pattern in the stock
Bluebird bio Inc [NASDAQ: BLUE] price surged by 1.38 percent to reach at $0.0. The one-year BLUE stock forecast points to a potential upside of 83.0. The average equity rating for BLUE stock is currently 2.80, trading closer to a bullish pattern in the stock
Bluebird bio Inc [NASDAQ: BLUE] price surged by 0.12 percent to reach at $0.0. The one-year BLUE stock forecast points to a potential upside of 84.0. The average equity rating for BLUE stock is currently 2.80, trading closer to a bullish pattern in the stock
Bluebird bio Inc [NASDAQ: BLUE] price surged by 10.04 percent to reach at $0.05. The one-year BLUE stock forecast points to a potential upside of 81.0. The average equity rating for BLUE stock is currently 2.80, trading closer to a bullish pattern in the stock
Copyright © 2024, Powered by Smart TechOne
